SingleCellAnalysisMarket GlobalForecastto2026 SingleCellAnalysisMarketis expectedtoreach $6.3Billionby2026 Growingata CAGRof15.1%(2021–2026)
Theglobalsingle-cellanalysismarketisprojectedtoreachUSD 6.3billionby2026fromUSD3.1billionin2021,ataCAGRof 15.1%duringtheforecastperiod.
Theconsumablessegmentaccountedforthelargestshareoftheproduct segmentinthesingle-cellanalysismarketin2020. Consumablesaccountedforthelargestshareofthesingle-cellanalysismarketin2020. Thelargeshareofthissegmentcanprimarilybeattributedtothefrequentpurchaseof theseproductscomparedtoinstruments,whichareconsideredaone-timeinvestment. Thewideapplicationsofconsumablesinresearchandgeneticexploration,exosome analysis,andisolationofRNAandDNAarealsoexpectedtodrivemarketgrowth.
Theresearchapplicationssegmentaccountedforthelargestshareof theapplicationsegmentinthesingle-cellanalysismarketin2020 Basedonapplications,thesingle-cellanalysismarketissegmentedinto researchandmedicalapplications.Theresearchapplicationssegment accountedforthelargestshareofthesingle-cellanalysismarketin2020. Increasinggovernmentinitiativesinstemcellresearchandthewideusage ofsingle-cellanalysisincancerresearcharethemajorfactorsdrivingthe growthoftheresearchapplicationssegment.
KeyMarketPlayer
DanaherCorporation(US), MerckKGAA(Germany), QIAGENN.V.(Netherlands), ThermoFisherScientific,Inc.(US), PromegaCorporation(US), Illumina,Inc.(US), FluidigmCorporation(US), 10XGenomics(US),and CorningIncorporated(US).
